Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy in Diabetic Patients with Renal Insufficiency
2007-007546-36Phase 4Completed
- Sponsor
- Institute for Clinical and Experimental Medicine
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium bicarbonate in contrast-induced nephropathy (CIN) (2 arms), sponsored by Institute for Clinical and Experimental Medicine. Primary endpoint: Maximal change in plasma creatinine within postcontrast days 1 and 2 versus precontrast level. Started Jan 2008; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on 2007-007546-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007546-36.